why choose us

Clinical Trials Search

Showing 15,170 of 132,656 result(s)
A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment

Status: ACTIVE_NOT_RECRUITING

Condition: Rhegmatogenous Retinal Detachment - Macula Off

Interventions: ONL1204 Ophthalmic Solution at one of two doses delivered via intravitreal injection

Date: 2023-02-07

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Status: Completed

Condition: Breast Cancer

Interventions: Participants will receive tucatinib 300mg by mouth twice daily continuously (days 1-28) of each 28 day cycle.

Date: 2023-02-07

Steroids in Occipital Nerve Block for Treatment of Headache

Status: Completed

Condition: Headache

Interventions: 2 mL of bupivacaine 0.5% (5 mg;mL) injected at the origin of each bilateral greater and lesser occipital nerves

Date: 2023-02-07

WayToServePlus: Improving Responsible Alcohol Service Ph II

Status: Completed

Condition: Alcohol Drinking

Interventions: Investigators will test WayToServe Plus in-service component's ability to increase refusal of service to intoxicated patrons in a randomized tria

Date: 2023-02-07

Treatment of Stress and Anxiety in MCI;Mild ADRD

Status: Completed

Condition: Anxiety

Interventions: Brief computerized treatment for anxiety sensitivity

Date: 2023-02-07

BIOSTREAM.HF HeartInsight

Status: COMPLETED

Condition: Heart Failure

Interventions: HeartInsight is activated at enrollment.
The attending physicians are free on how to integrate HeartInsight in the patient care.
Any treatme

Date: 2023-02-07

A Pilot Randomized Controlled Trial: CoINTEGRATE

Status: COMPLETED

Condition: Neurocognitive Disorders

Interventions:

Participants that score 1-1.5 standard deviation (SD) below the norm for age and education on 2 cognitive domains will receive an intensive program

Date: 2023-02-07

Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence

Status: COMPLETED

Condition: Glioblastoma

Interventions: Neuronavigated targeted biopsy sampling.
Supramarginal resection including high-risk areas of recurrence defined by a radiomics-based model.

Date: 2023-02-07

Istradefylline Effect Protocol on Parkinson's Disease Tremor

Status: COMPLETED

Condition: Parkinson Disease

Interventions: Istradefylline targets adenosine A2A receptors in the basal ganglia, by inhibiting the indirect pathway It is an adjunctive treatment to carbidopa-lev

Date: 2023-02-07

[18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)

Status: COMPLETED

Condition: Glioblastoma Multiforme of Brain

Interventions: Injection of the 18F-fluoropivalate (18F-FPIA) radiotracer followed by a whole brain static PET-CT scan.

Date: 2023-02-07